Biosimilars Pathway: A Far Cry From Hatch-Waxman
On March 23, 2010, President Obama signed into law Pub. Law. No. 111-148, the APPROVAL PATHWAY FOR BIOSIMILAR BIOLOGICAL PRODUCTS (i.e., Biosimilars Pathway), a component of the Patient Protection and Affordable...To view the full article, register now.
Already a subscriber? Click here to view full article